Best TWAS P=1.04e-10 · Best GWAS P=1.25e-09 conditioned to 0.331
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adrenal Gland | CHMP4C | 0.36 | 0.30 | enet | 31 | 0.28 | 9.0e-11 | -6.1 | 5.3 | 9.0e-08 | -0.87 | 0 | 1.00 | FALSE |
2 | GTEx | Colon Transverse | CHMP4C | 0.59 | 0.34 | lasso | 8 | 0.34 | 6.5e-17 | -6.1 | 5.9 | 3.5e-09 | -0.99 | 0 | 1.00 | FALSE |
3 | GTEx | Esophagus Mucosa | CHMP4C | 0.57 | 0.42 | lasso | 4 | 0.43 | 3.7e-31 | -6.1 | 6.0 | 2.4e-09 | -0.99 | 0 | 1.00 | FALSE |
4 | GTEx | Lung | CHMP4C | 0.37 | 0.21 | lasso | 6 | 0.20 | 2.4e-15 | -6.1 | 6.1 | 1.1e-09 | -0.99 | 0 | 1.00 | FALSE |
5 | GTEx | Pancreas | CHMP4C | 0.59 | 0.42 | lasso | 6 | 0.41 | 1.3e-18 | -6.1 | 6.2 | 6.6e-10 | -1.00 | 0 | 1.00 | FALSE |
6 | GTEx | Skin Not Sun Exposed Suprapubic | CHMP4C | 0.47 | 0.32 | lasso | 8 | 0.32 | 5.8e-18 | -6.1 | 5.9 | 3.0e-09 | -0.98 | 0 | 1.00 | FALSE |
7 | GTEx | Skin Sun Exposed Lower leg | CHMP4C | 0.43 | 0.27 | lasso | 7 | 0.27 | 7.8e-23 | -6.1 | 5.8 | 6.0e-09 | -0.98 | 0 | 1.00 | FALSE |
8 | GTEx | Thyroid | CHMP4C | 0.55 | 0.41 | lasso | 3 | 0.42 | 5.4e-35 | -6.1 | 6.1 | 1.3e-09 | -0.99 | 0 | 1.00 | FALSE |
9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | CHMP4C | 0.45 | 0.17 | lasso | 1 | 0.15 | 5.1e-13 | -6.1 | 6.1 | 1.3e-09 | -1.00 | 0 | 1.00 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CHMP4C | 0.47 | 0.24 | lasso | 4 | 0.24 | 2.3e-48 | -6.1 | 6.0 | 1.9e-09 | -0.99 | 0 | 1.00 | FALSE |
11 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | CHMP4C | 0.24 | 0.16 | lasso | 6 | 0.16 | 4.0e-08 | -6.1 | 6.0 | 2.2e-09 | -0.99 | 0 | 1.00 | FALSE |
12 | The Cancer Genome Atlas | Colon Adenocarcinoma | CHMP4C | 0.75 | 0.38 | lasso | 8 | 0.36 | 4.7e-22 | -6.1 | 6.1 | 1.3e-09 | -0.99 | 0 | 1.00 | FALSE |
13 | The Cancer Genome Atlas | Esophageal Carcinoma | CHMP4C | 0.46 | 0.03 | enet | 13 | 0.16 | 1.2e-05 | -6.1 | 6.5 | 1.0e-10 | -0.86 | 0 | 0.99 | TRUE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CHMP4C | 0.35 | 0.21 | lasso | 3 | 0.20 | 1.7e-22 | -6.1 | 6.1 | 1.3e-09 | -1.00 | 0 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CHMP4C | 0.54 | 0.23 | lasso | 1 | 0.23 | 5.8e-26 | -6.1 | 6.1 | 1.3e-09 | -1.00 | 0 | 1.00 | FALSE |
16 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | CHMP4C | 0.61 | 0.26 | lasso | 6 | 0.27 | 1.5e-15 | -6.1 | 5.9 | 3.1e-09 | -0.99 | 0 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Lung Adenocarcinoma | CHMP4C | 0.54 | 0.27 | lasso | 2 | 0.27 | 6.4e-32 | -6.1 | 6.2 | 7.0e-10 | -1.00 | 0 | 1.00 | FALSE |
18 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | CHMP4C | 0.15 | 0.08 | lasso | 2 | 0.07 | 2.3e-08 | -6.1 | 6.1 | 1.3e-09 | -1.00 | 0 | 1.00 | FALSE |
19 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | CHMP4C | 0.45 | 0.22 | enet | 8 | 0.25 | 9.0e-17 | -6.1 | 6.1 | 8.7e-10 | -0.90 | 0 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | CHMP4C | 0.57 | 0.30 | lasso | 2 | 0.28 | 4.6e-12 | -6.1 | 6.0 | 1.5e-09 | -0.99 | 0 | 1.00 | FALSE |
21 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CHMP4C | 0.64 | 0.37 | enet | 9 | 0.38 | 1.1e-41 | -6.1 | 6.1 | 1.1e-09 | -0.98 | 0 | 1.00 | FALSE |
22 | The Cancer Genome Atlas | Rectum Adenocarcinoma | CHMP4C | 0.84 | 0.59 | lasso | 4 | 0.63 | 1.5e-18 | -6.1 | 5.8 | 7.5e-09 | -0.97 | 0 | 1.00 | FALSE |
23 | The Cancer Genome Atlas | Stomach Adenocarcinoma | CHMP4C | 0.52 | 0.28 | lasso | 8 | 0.29 | 1.7e-21 | -6.1 | 6.1 | 1.1e-09 | -0.96 | 0 | 1.00 | FALSE |
24 | The Cancer Genome Atlas | Thyroid Carcinoma | CHMP4C | 0.73 | 0.49 | lasso | 9 | 0.50 | 2.6e-55 | -6.1 | 6.0 | 1.4e-09 | -0.99 | 0 | 1.00 | FALSE |
25 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | CHMP4C | 0.48 | 0.24 | lasso | 2 | 0.23 | 3.9e-07 | -6.1 | 5.4 | 8.0e-08 | -0.98 | 0 | 1.00 | FALSE |